Search research articles
Contact Us
Filters
Showing results (51-60 of 68) with videos related to
Page
of 7
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
July 22, 2025
Corrigendum to "A naturalistic retrospective evaluation of the utility of pharmacogenetic testing based on CYP2D6 and CYP2C19 profiling in antidepressants treatment in a cohort of patients with major depressive disorder" [Progress in Neuropsychopharmacology and Biological Psychiatry (2025) 111292]
Alessio Squassina, Pasquale Paribello, Marco Pinna, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
February 19, 2025
A naturalistic retrospective evaluation of the utility of pharmacogenetic testing based on CYP2D6 e CYP2C19 profiling in antidepressants treatment in a cohort of patients with major depressive disorder
Alessio Squassina, Pasquale Paribello, Marco Pinna, et al.
The International Journal of Neuropsychopharmacology
|
September 24, 2025
Identification of peripheral biomarkers through metabolomic analysis in patients with bipolar disorder treated with mood stabilizers: an exploratory study
Cristina Piras, Claudia Pisanu, Martina Spada, et al.
The Pharmacogenomics Journal
|
April 22, 2025
Association of pharmacodynamic genes with treatment outcomes in major depressive disorder: results from a Sardinian cohort
Pasquale Paribello, Mirko Manchia, Marco Pinna, et al.
Frontiers in Psychiatry
|
August 14, 2025
Identifying molecular signatures of post-traumatic stress disorder vulnerability and progression in a longitudinal study: a study protocol
Federico Suprani, Pasquale Paribello, Giulia Federica Mancini, et al.
Frontiers in Psychiatry
|
January 1, 2026
Factors influencing patient decision-making on a multimodal precision medicine algorithm for depression: a qualitative European multicentre study of the PROMPT consortium
Rosa Glaser, Johannes C S Zang, Britta Kelch, et al.
International Journal of Bipolar Disorders
|
May 9, 2017
Long-term lithium treatment in bipolar disorder: effects on glomerular filtration rate and other metabolic parameters
Leonardo Tondo, Maria Abramowicz, Martin Alda, et al.
Frontiers in Psychiatry
|
November 20, 2025
Attitudes towards a multimodal precision medicine algorithm for predicting treatment response in depression: findings from a large cross-sectional European survey
Viktor T H Wahner, Johannes C S Zang, Rosa Glaser, et al.
Biological Psychiatry
|
October 12, 2024
Refining Criteria for a Neurodevelopmental Subphenotype of Bipolar Disorders: A FondaMental Advanced Centers of Expertise for Bipolar Disorders Study
Antoine Lefrere, Ophélia Godin, Stéphane Jamain, et al.
Frontiers in Psychiatry
|
February 13, 2024
An integrated precision medicine approach in major depressive disorder: a study protocol to create a new algorithm for the prediction of treatment response
Bernhard T Baune, Alessandra Minelli, Bernardo Carpiniello, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 68) with videos related to
Sort By:
Page
of 7
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
July 22, 2025
Corrigendum to "A naturalistic retrospective evaluation of the utility of pharmacogenetic testing based on CYP2D6 and CYP2C19 profiling in antidepressants treatment in a cohort of patients with major depressive disorder" [Progress in Neuropsychopharmacology and Biological Psychiatry (2025) 111292]
Alessio Squassina, Pasquale Paribello, Marco Pinna, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
February 19, 2025
A naturalistic retrospective evaluation of the utility of pharmacogenetic testing based on CYP2D6 e CYP2C19 profiling in antidepressants treatment in a cohort of patients with major depressive disorder
Alessio Squassina, Pasquale Paribello, Marco Pinna, et al.
The International Journal of Neuropsychopharmacology
|
September 24, 2025
Identification of peripheral biomarkers through metabolomic analysis in patients with bipolar disorder treated with mood stabilizers: an exploratory study
Cristina Piras, Claudia Pisanu, Martina Spada, et al.
The Pharmacogenomics Journal
|
April 22, 2025
Association of pharmacodynamic genes with treatment outcomes in major depressive disorder: results from a Sardinian cohort
Pasquale Paribello, Mirko Manchia, Marco Pinna, et al.
Frontiers in Psychiatry
|
August 14, 2025
Identifying molecular signatures of post-traumatic stress disorder vulnerability and progression in a longitudinal study: a study protocol
Federico Suprani, Pasquale Paribello, Giulia Federica Mancini, et al.
Frontiers in Psychiatry
|
January 1, 2026
Factors influencing patient decision-making on a multimodal precision medicine algorithm for depression: a qualitative European multicentre study of the PROMPT consortium
Rosa Glaser, Johannes C S Zang, Britta Kelch, et al.
International Journal of Bipolar Disorders
|
May 9, 2017
Long-term lithium treatment in bipolar disorder: effects on glomerular filtration rate and other metabolic parameters
Leonardo Tondo, Maria Abramowicz, Martin Alda, et al.
Frontiers in Psychiatry
|
November 20, 2025
Attitudes towards a multimodal precision medicine algorithm for predicting treatment response in depression: findings from a large cross-sectional European survey
Viktor T H Wahner, Johannes C S Zang, Rosa Glaser, et al.
Biological Psychiatry
|
October 12, 2024
Refining Criteria for a Neurodevelopmental Subphenotype of Bipolar Disorders: A FondaMental Advanced Centers of Expertise for Bipolar Disorders Study
Antoine Lefrere, Ophélia Godin, Stéphane Jamain, et al.
Frontiers in Psychiatry
|
February 13, 2024
An integrated precision medicine approach in major depressive disorder: a study protocol to create a new algorithm for the prediction of treatment response
Bernhard T Baune, Alessandra Minelli, Bernardo Carpiniello, et al.
Page
of 7